Kaleido Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	2016
Period Ending	May '25 May 30, 2025	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	2016
Market Capitalization	0	102	327	151	-	-	Upgrade
Market Cap Growth	-68.91%	-68.91%	117.13%	-	-	-	Upgrade
Enterprise Value	-	68	294	84	-	-	Upgrade
Last Close Price	0.00	2.39	9.10	5.02	-	-	Upgrade
PS Ratio	0.00	92.21	335.83	-	-	-	Upgrade
PB Ratio	0.00	9.60	15.98	3.09	-	-	Upgrade
P/TBV Ratio	0.00	9.60	15.98	3.09	-	-	Upgrade
EV/Sales Ratio	-	61.29	301.27	-	-	-	Upgrade
Debt / Equity Ratio	2.05	2.05	1.02	0.42	0.26	1.69	Upgrade
Asset Turnover	0.02	0.02	0.01	-	-	-	Upgrade
Quick Ratio	1.33	1.33	2.78	6.87	6.73	7.40	Upgrade
Current Ratio	1.43	1.43	2.93	7.06	6.75	7.41	Upgrade
Return on Equity (ROE)	-580.57%	-580.57%	-235.29%	-163.10%	-187.68%	-729.65%	Upgrade
Return on Assets (ROA)	-99.93%	-99.93%	-69.77%	-64.62%	-65.35%	-94.55%	Upgrade
Return on Capital (ROIC)	-148.23%	-148.23%	-89.16%	-76.69%	-79.32%	-123.23%	Upgrade
Earnings Yield	-2118442.05%	-88.69%	-24.93%	-57.25%	-	-	Upgrade
FCF Yield	-1835358.99%	-76.84%	-20.02%	-52.64%	-	-	Upgrade
Buyback Yield / Dilution	-25.14%	-25.14%	-30.14%	-403.18%	-14.29%	-19.13%	Upgrade

Updated Apr 1, 2022. Source: S&P Global Market Intelligence. Standard template. Financial Sources.